11-17612613-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001292063.2(OTOG):​c.6293-7C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00152 in 1,548,930 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0079 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00082 ( 17 hom. )

Consequence

OTOG
NM_001292063.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00009001
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.387

Publications

0 publications found
Variant links:
Genes affected
OTOG (HGNC:8516): (otogelin) The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
OTOG Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 18B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 11-17612613-C-T is Benign according to our data. Variant chr11-17612613-C-T is described in ClinVar as Benign. ClinVar VariationId is 226903.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00788 (1200/152234) while in subpopulation AFR AF = 0.0277 (1151/41524). AF 95% confidence interval is 0.0264. There are 14 homozygotes in GnomAd4. There are 569 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001292063.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OTOG
NM_001292063.2
MANE Select
c.6293-7C>T
splice_region intron
N/ANP_001278992.1
OTOG
NM_001277269.2
c.6329-7C>T
splice_region intron
N/ANP_001264198.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OTOG
ENST00000399397.6
TSL:5 MANE Select
c.6293-7C>T
splice_region intron
N/AENSP00000382329.2
OTOG
ENST00000399391.7
TSL:5
c.6329-7C>T
splice_region intron
N/AENSP00000382323.2
OTOG
ENST00000342528.2
TSL:2
n.3631-7C>T
splice_region intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00788
AC:
1199
AN:
152116
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0278
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00160
AC:
237
AN:
147930
AF XY:
0.00114
show subpopulations
Gnomad AFR exome
AF:
0.0302
Gnomad AMR exome
AF:
0.000982
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.000466
GnomAD4 exome
AF:
0.000825
AC:
1152
AN:
1396696
Hom.:
17
Cov.:
31
AF XY:
0.000700
AC XY:
482
AN XY:
688740
show subpopulations
African (AFR)
AF:
0.0308
AC:
972
AN:
31566
American (AMR)
AF:
0.00112
AC:
40
AN:
35578
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25066
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35718
South Asian (SAS)
AF:
0.000152
AC:
12
AN:
78970
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48102
Middle Eastern (MID)
AF:
0.000706
AC:
4
AN:
5666
European-Non Finnish (NFE)
AF:
0.0000315
AC:
34
AN:
1078098
Other (OTH)
AF:
0.00155
AC:
90
AN:
57932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
61
121
182
242
303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00788
AC:
1200
AN:
152234
Hom.:
14
Cov.:
32
AF XY:
0.00764
AC XY:
569
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0277
AC:
1151
AN:
41524
American (AMR)
AF:
0.00229
AC:
35
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68002
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
56
112
167
223
279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00444
Hom.:
5
Bravo
AF:
0.00912
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 05, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

6329-7C>T in intron 36 of OTOG: This variant is not expected to have clinical si gnificance because it has been identified in 6.8% (12/176) of Yoruba (Nigerian) chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi .nlm.nih.gov/projects/SNP; dbSNP rs143985593).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
2.1
DANN
Benign
0.53
PhyloP100
-0.39
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000090
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143985593; hg19: chr11-17634160; API